Biogen's product revenue 2021-2023, by therapeutic area
This statistic shows Biogen's product revenues from 2021 to 2023, by therapeutic area. Multiple sclerosis products generated around 4.7 billion U.S. dollars in 2023. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer.